You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 17, 2025

Details for Patent: 6,884,793


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,884,793
Title: Combination preparation for contraception based on natural estrogens
Abstract:The combination preparation for contraception includes from 2 to 4 first stage daily dosage portions each including an effective amount of at least one natural estrogen as sole active ingredient, from 16 to 22 second stage daily dosage portions each including an effective amount of a combination of at least one natural estrogen and at least one natural or synthetic gestogen as active ingredient; from 2 to 4 third stage daily dosage portions each including an effective amount of at least one natural estrogen as sole active ingredient; and from 2 to 4 final stage daily dosage portions containing a pharmaceutically acceptable placebo. The estrogen may be estradiol, an estradiol compound that is metabolized to estradiol when taken into the body, a conjugated equine estrogen or a phytoestrogen. The natural or synthetic gestogen can be natural progesterone or a synthetic gestogens, such as medroxyprogesterone acetate.
Inventor(s): Dittgen; Michael (Apolda, DE), Fricke; Sabine (Jena, DE), Hoffmann; Herbert (Jena, DE), Moore; Claudia (Jena, DE), Oettel; Michael (Jena, DE), Ostertag; Monika (Gottingen, DE)
Assignee: Jenapharm GmbH & Co. KG (Jena, DE)
Application Number:09/950,915
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,884,793: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to make, use, and sell their inventions. The United States Patent 6,884,793, like any other patent, is a complex document that outlines the scope and claims of an invention. This article will delve into the details of this patent, exploring its background, the patent system in the U.S., the significance of patent claims, and the broader patent landscape.

Background of U.S. Patent 6,884,793

To analyze U.S. Patent 6,884,793, one must first understand the context in which it was granted. This patent, like others, was issued by the United States Patent and Trademark Office (USPTO) after a thorough examination process. The patent details the invention, its specifications, and the claims that define the scope of the invention.

The U.S. Patent System

The U.S. patent system has undergone significant changes over the years, particularly with the passage of the America Invents Act (AIA) in 2011. Prior to the AIA, the U.S. used a first-to-invent system, where the first person to invent a claimed invention had priority and was entitled to a patent, even if another inventor filed a patent application first[2].

First-to-Invent vs. First-Inventor-to-File

The AIA transformed the system to a first-inventor-to-file system, where the first person to file a patent application on an invention has priority, regardless of who invented it first. This change aligned the U.S. with international standards and simplified the process by eliminating interference proceedings, which were administrative priority contests[2].

Significance of Patent Claims

Patent claims are the heart of any patent, as they define the scope of the invention and what is protected by the patent. These claims must be clear, concise, and supported by the specification of the patent.

Types of Claims

There are several types of claims, including independent claims and dependent claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim[3].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset helps in understanding the trends and scope of patent claims over time[3].

Analyzing the Claims of U.S. Patent 6,884,793

To analyze the specific claims of U.S. Patent 6,884,793, one would need to review the patent document itself. Here are some key steps:

Reading the Specification

The specification section of the patent describes the invention in detail, including its background, summary, and detailed description. This section provides the context for understanding the claims.

Identifying Independent and Dependent Claims

Independent claims are typically broader and define the invention as a whole, while dependent claims narrow down the invention by adding specific limitations.

Understanding Claim Language

The language used in claims is precise and technical. Each claim must be read in light of the specification to understand what is being claimed.

Patent Litigation and Enforcement

Patent litigation is a critical aspect of the patent landscape. Patent owners may need to assert their patents against infringers to protect their rights.

Factors Affecting Patent Litigation

Several factors contribute to patent litigation, including the rise of non-practicing entities (NPEs) that own patents but do not make products. These entities often assert their patents for profit, leading to an increase in patent infringement lawsuits[1].

Impact of AIA on Patent Litigation

The AIA introduced new proceedings such as post-grant review and inter partes review, which can affect patent litigation by providing additional avenues for challenging patent validity before the USPTO[2].

The Broader Patent Landscape

The patent landscape is influenced by various factors, including technological trends, global competition, and policy changes.

Technological Trends

Patents are classified under various technological fields, and trends in these fields can indicate areas of innovation. For example, the number of patents granted in technology areas such as software, biotechnology, and renewable energy has seen significant growth over the years[4].

Global Competition

The U.S. patent system operates within a global context. International patent classifications and the first-inventor-to-file system ensure that U.S. inventors and companies can compete effectively on the global stage[2].

Policy Considerations

Policy changes, such as the consideration of a small claims patent court, aim to make the patent system more accessible and efficient for small inventors and businesses. This could potentially reduce the cost and complexity of patent litigation[5].

Case Studies and Examples

Historical examples illustrate the importance of patent claims and the patent system. For instance, the dispute between Elias Howe and Isaac Singer over the sewing machine patent highlights how patent claims can be crucial in determining the rights to an invention[1].

"History is filled with examples of successful inventors who did not develop products based on the technologies they patented. For example, Elias Howe patented a key component of the sewing machine—a mechanism for making a lockstitch—but it was Isaac Singer who most successfully brought these machines into the homes of thousands of Americans by obtaining crucial patents of his own and paying Howe and other inventors to license the technology described in their patents."[1]

Key Takeaways

  • Patent Claims: The claims section of a patent is crucial as it defines the scope of the invention.
  • First-Inventor-to-File System: The AIA changed the U.S. patent system to a first-inventor-to-file system, aligning it with international standards.
  • Patent Litigation: Factors such as the rise of NPEs and new AIA proceedings can significantly impact patent litigation.
  • Global Context: The U.S. patent system operates within a global framework, influenced by international classifications and trends.
  • Policy Changes: Ongoing policy discussions, such as the potential for a small claims patent court, aim to improve the efficiency and accessibility of the patent system.

FAQs

What is the significance of patent claims in a patent?

Patent claims define the scope of the invention and what is protected by the patent. They must be clear, concise, and supported by the specification.

How has the AIA impacted the U.S. patent system?

The AIA changed the U.S. patent system from a first-to-invent to a first-inventor-to-file system, eliminated interference proceedings, and introduced new post-grant review proceedings.

What are non-practicing entities (NPEs), and how do they affect patent litigation?

NPEs are entities that own patents but do not make products. They often assert their patents for profit, leading to an increase in patent infringement lawsuits.

Why is the consideration of a small claims patent court important?

A small claims patent court could make the patent system more accessible and efficient for small inventors and businesses by reducing the cost and complexity of patent litigation.

How do global trends influence the U.S. patent landscape?

Global trends in technology and innovation, along with international patent classifications, influence the U.S. patent landscape and ensure that U.S. inventors and companies can compete globally.

Sources

  1. United States Government Accountability Office. Assessing Factors That Affect Patent Infringement Litigation Could Help Improve Patent Quality. Report to Congressional Committees, August 2013.
  2. United States Court of Appeals for the Federal Circuit. SNIPR TECHNOLOGIES LIMITED v. ROCKEFELLER UNIVERSITY. Case: 22-1260, Document: 47, Page: 2, Filed: 07/14/2023.
  3. United States Patent and Trademark Office. Patent Claims Research Dataset. August 28, 2017.
  4. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  5. Administrative Conference of the United States. U.S. Patent Small Claims Court. April 28, 2022.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,884,793

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 6,884,793

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 40 253Oct 28, 1995

International Family Members for US Patent 6,884,793

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 0770388 ⤷  Try for Free CA 2009 00016 Denmark ⤷  Try for Free
European Patent Office 0770388 ⤷  Try for Free PA2009004 Lithuania ⤷  Try for Free
European Patent Office 0770388 ⤷  Try for Free PA2009004,C0770388 Lithuania ⤷  Try for Free
European Patent Office 0770388 ⤷  Try for Free 91643 Luxembourg ⤷  Try for Free
European Patent Office 0770388 ⤷  Try for Free SPC/GB09/026 United Kingdom ⤷  Try for Free
European Patent Office 0770388 ⤷  Try for Free C00770388/01 Switzerland ⤷  Try for Free
European Patent Office 0770388 ⤷  Try for Free 9/2009 Austria ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.